Navigation Links
ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2011 and to Provide a Business Update
Date:5/11/2011

ADDISON, Texas, May 11, 2011 /PRNewswire/ -- ULURU Inc. (NYSE AMEX: ULU) today announced that it has scheduled a conference call to discuss the first quarter ended March 31, 2011 financial results and to provide a general business update on Tuesday, May 17, 2011 at 9:00 a.m. Eastern Time.

To participate in the conference call please dial (800) 357-0498, for international callers dial (850) 429-1388 (access code 23748#) five to ten minutes prior to the initiation of the teleconference.  If you are unable to listen to the live broadcast, a replay of the call will be available starting on May 17, 2011 two hours following the end of the call until May 31, 2011 at 11:59 p.m. Eastern Time.  For the U.S. replay, please dial (866) 415-9493 for international callers dial (585) 419-6446 (access code 23748#). You may also access the replay of the call two hours following the end of the call until May 31, 2011 at 11:59 p.m. Eastern Time via the web by logging onto http://app.replayrecorder.com/multipoint/.

About ULURU Inc.:

ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers with improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex® Aggregate technology and OraDisc™ transmucosal delivery system. For more information about ULURU Inc., please visit www.uluruinc.com.  For more information about Altrazeal®, please visit www.Altrazeal.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2010 and other reports filed by us with the Securities and Exchange Commission.

Contact: Company
Kerry P. Gray
President & CEO
Terry K. Wallberg
Vice President & CFO
(214) 905-5145


'/>"/>
SOURCE ULURU Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ULURU Inc. Announces the Filing of a 510(k) Application for Altrazeal® Collagen
2. ULURU Inc. Announces Going Concern Qualification
3. ULURU Inc. Announces Commercial Exhibit and Scientific Presentations at the SAWC/WHS National Wound Symposium
4. ULURU Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 2010
5. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2010 and to Provide a Business Update
6. ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®s Label Claim
7. ULURU Inc. Receives Letter of Non-Compliance From NYSE Amex
8. ULURU Inc. Announces Agreement With Exciton to Develop Antimicrobial Dressing
9. ULURU Inc. to Raise $500,000 in Registered Direct Offering
10. ULURU Inc. Reports Third Quarter 2010 Financial Results
11. ULURU Inc. Provides Altrazeal® Clinical Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... ... recruitment firm Slone Partners is pleased to announce the placement of Suzanne ... of North American Capital Sales at HTG Molecular . , In ... commercialization of the HTG EdgeSeq system and associated reagents in North America. , Headquartered ...
Breaking Medicine News(10 mins):